SCHEMBL30682010

SCHEMBL30682010

Cc1cc2c(nc1O)CNC2

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8260694 0.80 DRD2 (0.35)
SCHEMBL10315548 0.74
SCHEMBL22342840 0.69 SLC9A1 (0.44)
SCHEMBL29750144 0.69 PNMT (0.37)
SCHEMBL10139767 0.69 PNMT (0.37)
SCHEMBL9156518 0.66 KDM4E (0.42) ACHE
SCHEMBL13725248 0.66 PDE3B (0.41) ACHE
SCHEMBL30101526 0.65 HTR2C (0.36)
SCHEMBL17984826 0.65 HTR2C (0.36)
SCHEMBL1528492 0.64 HTR2C (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4514789-A1 <SUP2/>? <SUB2/>?V?BICYCLIC HETEROCYCLIC AMIDE INHIBITORS OF NA1.8 FOR THE TREATMENT OF PAIN SiteOne Therapeutics, Inc. (US) 2025-03-05 EP disclosed
WO-2023211990-A1 BICYCLIC HETEROCYCLIC AMIDE INHIBITORS OF NA V1.8 FOR THE TREATMENT OF PAIN SITEONE THERAPEUTICS, INC. (US) 2023-11-02 WO disclosed